Ind-Swift Labs to sell API and CRAMS business to Synthimed for Rs 1,650cr
In a groundbreaking move that has left the pharmaceutical sector buzzing, the Board of Directors of Ind-Swift Laboratories Limited ("Ind-Swift") announced the blockbuster sale of ... Read More
India-based Piramal Pharma secures $490m investment from Carlyle Group
The Carlyle Group has signed a deal worth around $490 million with Piramal Enterprises, to acquire a stake of 20% from the Indian conglomerate's pharma ... Read More
Piramal Pharma acquires solid oral dosage drug product facility in Sellersville
Piramal Pharma Solutions has agreed to acquire the solid oral dosage drug product manufacturing facility of G&W Laboratories in Sellersville, Pennsylvania for an undisclosed price. ... Read More